Onco-Innovations Limited ONNVF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 15.30K | -- | 50.40K | 14.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 15.30K | -- | 50.40K | 14.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 15.30K | -- | 50.40K | 14.20K |
| SG&A Expenses | 936.00K | 677.20K | 1.45M | 2.00M | 398.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.40M | 843.60K | 1.67M | 2.33M | 596.50K |
| Operating Income | -1.40M | -828.30K | -1.67M | -2.28M | -582.30K |
| Income Before Tax | -2.40M | -1.08M | -2.19M | -2.60M | -1.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.40M | -1.08M | -2.19M | -2.60M | -1.93M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.40M | -1.08M | -2.19M | -2.60M | -1.93M |
| EBIT | -1.40M | -828.30K | -1.67M | -2.28M | -582.30K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.04 | -0.02 | -0.04 | -0.05 | -0.04 |
| Normalized Basic EPS | -0.03 | -0.01 | -0.02 | -0.03 | -0.02 |
| EPS Diluted | -0.04 | -0.02 | -0.04 | -0.05 | -0.04 |
| Normalized Diluted EPS | -0.03 | -0.01 | -0.02 | -0.03 | -0.02 |
| Average Basic Shares Outstanding | 59.92M | 58.55M | 56.49M | 54.33M | 52.50M |
| Average Diluted Shares Outstanding | 59.92M | 58.55M | 56.49M | 54.33M | 52.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |